THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
Charles Y.C. PAK,Khashayar SAKHAEE,Orson W. MOE
申请号：
US16563439
公开号：
US20200078395A1
申请日:
2019.09.06
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed is the use of an effervescent preparation of calcium and magnesium with additional citric acid in a defined ratio to reduce serum C-carboxy-terminal telopeptide (CTX), increase urinary Mg, increase FEMg, increase urinary citrate, reduce urinary ammonium, and decrease putative serum fibroblast growth factor 23 (FGF23) in subjects taking proton pump inhibitors.
